Navigation Links
Exubera could mean the end of an insulin injection era for diabetics

Diabetes and cancer remain the most feared diseases all around the world. Researchers have now come up with an insulin inhaler, potentially offering adult diabetics an alternative to injections// for controlling their blood sugar. The drug is yet to be approved by the FDA.

If approved, the drug, known as Exubera, would mean an end to the insulin injections taken by millions worldwide. The product works by releasing an insulin-powder cloud inhaled via a handheld plastic machine similar to the inhalers used for asthma and allergy. The drug has been in development for a decade and is now backed by a joint venture between Pfizer, Sanofi-Aventis and Nektar Therapeutics.

Pfizer presented several studies showing Exubera controlled blood sugar as well as insulin shots for up to two years in patients with both forms of diabetes. Questions remain about whether adult Type 1 diabetics can expect to achieve tight glycemic control with Exubera.

Up to two-thirds of all diabetics do not adequately control their blood sugar, according to the American Academy of Clinical Endocrinologists. Poor control over the long term can lead to blood vessel and organ damage, blindness, and kidney failure and foot ailments.

Despite approval, many would still have to use needles, because the drug is not a replacement for the currently available longer-acting insulin. In addition, patients who smoke will be excluded from taking the drug, because of evidence that damage from cigarettes boosts patients` exposure to insulin.

'To have people rush to the this product saying, `I can throw away my syringes` ... is simply an incorrect message and that needs to be emphasized more,' said Dr. Paul D. Woolf, chief of medicine at Crozer Chester Medical Center in Upland, Pa., and acting chair of the advisory panel. I think the use of insulin without a needle, the siren call of that is almost irresistible,' said Rebecca W. Killion, the panel`s patient representative --
'"/>




Page: 1 2

Related medicine news :

1. New Drug Exubera (Oral Inhaled Insulin) To Be Monitored By Pfizer
2. Exubera is effective in diabetes patients with cold or flu
3. Virus Level could Predict Cervical Cancer Risk
4. Beware of the oral patch! It could be cancer!!!
5. Prozac miracle could end in disaster
6. Wonder drug - could end in disaster
7. Pollution could be a risk
8. Fright could be more harmful
9. Pregnant smokers could harm their child
10. Snoring could be a warning
11. Anthrax drug doxycycline could stunt fetal growth

Post Your Comments:
(Date:11/8/2009)... A jury of 8 people in the We...nty woman $2,300,000 in pain and suffering for a m..., James Tallman and Alicia Nocera of Thomas E. Cre...f of the plaintiff, Vita Monestersky and against t...mergency total abdominal hysterectomy at age 18. ...
(Date:11/8/2009)..., "One victory does not mean the battle is won," ...7 In a vote of 240-194,...nski-Smith Amendment to prohibit abortion mandates... ,, Americans United for Life Action President ...this amendment is a victory for the pro-life Ameri...
(Date:11/8/2009)..., WASHINGTON, Nov. 7 US...le Health Care for America Act, which will make he...rance companies accountable and increase access to...ublic option. ,, "Teddy Roosevelt, FDR and Harr...rector Alan Charney. "Today,s vote ranks among our...
(Date:11/8/2009)..., Calls for Swift Passage of H.R. 3961 to Secure ...PRNewswire-USNewswire/ -- Statement Attributable t...cal Association. ,, (Logo: http://www.newscom...AMA hails the passage of the House health reform b... patients and physicians and calls for swift passa...
(Date:11/8/2009)..., AARP Praises House Passage of Health Care Refor...en Medicare, improve coverage for all Americans ,...day, the United States House of Representatives pa...form legislation that would strengthen Medicare fo...anies that prices millions of Americans out of aff...
Breaking Medicine News(10 mins):Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3
...ation,(Nasdaq: MDTH ), a healthcare provider focu...ely the diagnosis and treatment of cardiovascular,... its first fiscal,quarter, which ended December 31...HMC"). As part of the,recapitalization, MedCath,s ...
...d deploying,cross- functional, yet sufficiently sp...eting leaders at pharmas and biotechs. However,bes...hare similar,structure, composition, and responsib...nds have a core team of three,to 10 people and 86 ...
... - DRAXIS Health Inc. (TSX:,DAX); (Nasdaq: DRAX )... and,the year ended December 31, 2007. Results for... quarter of 2006 were impacted by lower product sa...fourth quarter of 2007 relative to the same quarte...
...(ACE) Research Proves Dance Dance Rev...EGO, Feb. 7 Based on the growing popularity of,vi...lers in favor of more,full-body interaction, the A...,Crosse, focused on quantifying DDR,s potential ph...
....,(Nasdaq: NUVO ) today announced that it will ho... Investor Conference February 13, 2008 11:45 a...://www.corporate-ir.net/ireye/conflobby.zhtml?tick...p.m. ET (1:30 p.m. PT) Dr. Ted W. Love, Chairman ...
...r Air and Health Advocates Together to Educat...y, SOUTHBOROUGH, Mass., Feb. 7 Most Americans ar...ut did you know the Environmental,Protection Agenc...Five out of 10 Americans are unaware of this fact,...
Other Medicine News:Health News:MedCath Corporation Reports First Quarter Earnings 2Health News:MedCath Corporation Reports First Quarter Earnings 3Health News:MedCath Corporation Reports First Quarter Earnings 4Health News:MedCath Corporation Reports First Quarter Earnings 5Health News:MedCath Corporation Reports First Quarter Earnings 6Health News:MedCath Corporation Reports First Quarter Earnings 7Health News:MedCath Corporation Reports First Quarter Earnings 8Health News:MedCath Corporation Reports First Quarter Earnings 9Health News:MedCath Corporation Reports First Quarter Earnings 10Health News:MedCath Corporation Reports First Quarter Earnings 11Health News:MedCath Corporation Reports First Quarter Earnings 12Health News:Pharmaceutical Product Commercialization & Governance Best Practices: Securing Talent for Highly-Effective Brand Teams 2Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 2Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 3Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 4Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 5Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 6Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 7Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 8Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 9Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 10Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 11Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 12Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 13Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 14Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 15Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 16Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 17Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 18Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 19Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 20Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 21Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 22Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 23Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 24
(Date:11/6/2009)...RIS, November 6 , - Trial...olid for the,Treatment of Multi-Resistant Staphylo..., a speciality pharmaceutical company focused on t...designed to overcome the significant global,proble...s most advanced oral,antibacterial NXL103 (flopris...
(Date:11/5/2009)...RICHMOND, Calif., Nov. 5 ... a specialty pharmaceutical company focused on the...products that address important therapeutic needs ...ill host a webcast and teleconference with managem...s on Thursday, November 12, 2009, at 5:00 p.m. Eas...
(Date:11/5/2009)...TON, Calif., Nov. 5 Renee Cobos, M...rofessor of dermatology at the University of Calif...re experiencing tremendous results with Thermage C...r skin tightening and contouring, features a new v...acy and improves patient comfort. ,, "Thermage...
Breaking Medicine Technology:Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R) 2Adding Drug Doesnt Help Control Blood Pressure 59997 1Adding Drug Doesnt Help Control Blood Pressure 59997 2Buffalo neurologists investigate possible new underlying cause of MS 59993 1Buffalo neurologists investigate possible new underlying cause of MS 59993 2Buffalo neurologists investigate possible new underlying cause of MS 59993 3Buffalo neurologists investigate possible new underlying cause of MS 59993 4Sex based prenatal brain differences found 10503 1Sex based prenatal brain differences found 10503 2
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products: